Outcomes in Critically Ill Allogeneic Hematopoietic Stem-Cell Transplantation Recipients
Antoine Lafarge(Inserm), Élie Azoulay(Hôpital Saint-Louis), Naïke Bigé(Sorbonne Université), Nahéma Issa(Bordeaux Population Health), Lara Zafrani(Inserm), Djamel Mokart(Inserm), Patrice Chevallier(Hotel Dieu Hospital), Emmanuel Canet(Centre Hospitalier Universitaire de Nantes), Frédéric Pène(Centre National de la Recherche Scientifique), Jean‐Herlé Raphalen(Université Sorbonne Paris Nord), Laura Platon(Hôpital Lapeyronie), Michaël Darmon(Inserm), Anne‐Sophie Moreau(Université de Lille), Florent Wallet(Université Claude Bernard Lyon 1), Thibault Dupont(Assistance Publique – Hôpitaux de Paris), Anne Renault(Centre Hospitalier Régional Universitaire de Brest), Julien Mayaux(Sorbonne Université), Christian Récher(Institut universitaire du cancer de Toulouse Oncopole), Régis Peffault de la Tour(Université Paris Cité), Muriel Picard(Institut universitaire du cancer de Toulouse Oncopole)
Cited by 16
Related Papers
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals
|Annals of the American Thoracic Society|2018|723
Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2)
|The Lancet|2017|568
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
|The Lancet Haematology|2016|431